发明名称 |
DRY FORMULATION FOR TRANSCUTANEOUS IMMUNIZATION |
摘要 |
A transcutaneous immunization system delivers antigen to immune cells through the skin, and induces an immune response in an animal or human. For example, a skin-active adjuvant (e.g., an ADP-ribosylating exotoxin) can be used to induce an antigen-specific immune response (e.g., humoral and/or cellular effectors) after transcutaneous application of a dry formulation containing antigen and adjuvant to skin of the animal or human. The dry formulation may be a powder or a unit-dose patch. Use of adjuvant is not required if the antigen is sufficiently antigenic. Transcutaneous immunization may be induced with or without penetration enhancement.
|
申请公布号 |
WO0061184(A3) |
申请公布日期 |
2001.02.15 |
申请号 |
WO2000US08714 |
申请日期 |
2000.04.10 |
申请人 |
GLENN, GREGORY, M.;SCHARTON-KERSTEN, TANYA |
发明人 |
GLENN, GREGORY, M.;SCHARTON-KERSTEN, TANYA |
分类号 |
A61K9/14;A61K9/70;A61K39/00;A61K39/35;A61K39/39;A61K48/00;A61P31/00;A61P33/00;A61P35/00;A61P37/04;A61P43/00;(IPC1-7):A61K39/39;A61K9/00 |
主分类号 |
A61K9/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|